PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 And, Combined With HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-2601
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

PD-L1 Expression Combined With Microsatellite Instability/Cd8+ Tumor Infiltrating Lymphocytes as a Useful Prognostic Biomarker in Gastric Cancer

Scientific Reports
Multidisciplinary
2019English

PD-L1 Is a Direct Target of Cancer-Foxp3 in Pancreatic Ductal Adenocarcinoma (PDAC), and Combined Immunotherapy With Antibodies Against PD-L1 and CCL5 Is Effective in the Treatment of PDAC

Signal Transduction and Targeted Therapy
Cancer ResearchGenetics
2020English

ROR2 Is a Novel Prognostic Biomarker and a Potential Therapeutic Target in Leiomyosarcoma and Gastrointestinal Stromal Tumour

Journal of Pathology
Forensic MedicinePathology
2012English

JMJD6 Is a Tumorigenic Factor and Therapeutic Target in Neuroblastoma

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Skp2 Is a Promising Therapeutic Target in Breast Cancer

Frontiers in Oncology
Cancer ResearchOncology
2012English

P1.03-24 TMPRSS4: A Novel Prognostic Biomarker and Therapeutic Target in NSCLC

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

sCLU as Prognostic Biomarker and Therapeutic Target in Osteosarcoma

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

The Bromodomain BET Inhibitor JQ1 Suppresses Tumor Angiogenesis in Models of Childhood Sarcoma

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

Polo-Like Kinase 1 Is a Therapeutic Target in High-Risk Neuroblastoma

Clinical Cancer Research
Cancer ResearchOncology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy